Doliver Advisors LP Decreases Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Doliver Advisors LP has decreased its position in Intuitive Surgical by 34.8%, now owning 2,157 shares valued at approximately $1.17 million.
• Intuitive Surgical reported better-than-expected earnings with an EPS of $2.19 and revenue of $2.44 billion, exceeding analysts' estimates.
• Insiders have sold a total of 45,224 shares valued at around $21.7 million over the last quarter, with significant sales from both a director and an executive vice president.

Doliver Advisors LP lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 34.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,157 shares of the medical equipment provider's stock after selling 1,153 shares during the period. Doliver Advisors LP's holdings in Intuitive Surgical were worth $1,172,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Castleark Management LLC boosted its stake in Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares during the last quarter. Arlington Trust Co LLC lifted its holdings in shares of Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares in the last quarter. Aveo Capital Partners LLC boosted its position in shares of Intuitive Surgical by 37.4% during the first quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock valued at $390,000 after buying an additional 198 shares during the last quarter. Aaron Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after buying an additional 78 shares during the last quarter. Finally, Longbow Finance SA increased its holdings in Intuitive Surgical by 132.0% in the 1st quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock worth $9,756,000 after buying an additional 11,209 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $449.68 on Friday. The stock has a market capitalization of $161.20 billion, a PE ratio of 62.72, a P/E/G ratio of 4.78 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company's fifty day simple moving average is $485.67 and its 200-day simple moving average is $508.71.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the firm earned $1.78 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Zacks Research cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. UBS Group lifted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company raised their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director directly owned 1,074 shares of the company's stock, valued at $504,898.14. The trade was a 23.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 over the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.